• Publications
  • Influence
[Study of functional properties of chemically-modified hemoglobin during circulation in the blood channel].
Functional activity of the solutions of chemically modified hemoglobins (Hb) with different structure had been investigated during the replacement of acute fatal blood loss in dogs. It was found theExpand
[Study of the effectiveness of artificial oxygen carrier on the hemoglobin base in blood loss replacement in dogs].
The effectiveness of modified polyhemoglobin proposed as an artificial oxygen carrier (AOC) was evaluated in experiments on dogs with acute fatal hemorrhage. It was shown that total oxygenExpand
[Experimental assessment of the effectiveness of modified polyhemoglobin in the model of extreme hemodilution].
The efficacy of the modified polyhemoglobin suggested as an artificial oxygen transporting substitute was estimated in the model of extreme hemodilution in dogs. It was shown that O2 consumption inExpand
[An experimental study of the water balance and acid-base state of the blood during infusions of the plasma substitute oksiamal].
The influence of the plasma substitute oxyamal on shifts in the water and acid-base balance of the blood was studied in experiments on dogs with simulated severe hemorrhagic shock. Oxyamal therapy ofExpand
[Circulating blood plasma proteins in prolonged blood loss].
[Hepatoprotective properties of liproxol].
The experiments on rats with a model toxic liver damage (tetrachloromethane hepatitis) showed evidence of a high hepatoprotector activity of liproxol, representing a combination of eplir and lokheinExpand
[Injury to the bile ducts during surgery].
The authors had 51 patients with iatrogenic injuries to the bile ducts. This complication occurred most frequently in cholecystectomy (45 patients). The injury was localized in the distal segment ofExpand
  • 1
[Effect of polyhemoglobin composition on erythrocyte aggregation and circulation time in the vascular bed].
Aggregation of erythrocytes and circulation time of polyhemoglobins in blood plasma was estimated in the model of 50% blood loss compensation in vivo and in vitro using solutions of polyhemoglobinsExpand